Damian McNamara, MAVANCOUVER, Canada — Use of sodium glucose cotransporter-2 (SGLT2) inhibitors is associated with a reduced risk of gastrointestinal (GI) cancers among patients withtype 2 diabe

by Wynne Parry,Cornell UniversityGraphical Abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/jNaNet.2023.09.013In experiments of unprecedented scale, investigators at Weill Cornel